|
Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia
January 02, 2008WESTCHESTER, Ill. - A study published in the January 1 issue of the journal SLEEP finds that zolpidem extended-release 12.5 mg, taken three to seven nights per week for up to six months, provided sustained and significant improvements in sleep onset and maintenance, and also improved next-day concentration and morning sleepiness in people with insomnia.
The study focused on 1,018 patients between 18 and 64 years of age with chronic primary insomnia, who had difficulty initiating or maintaining sleep or experiencing non-restorative sleep for three months or greater. The subjects took either a single dose of zolpidem extended-release or a placebo from three to seven nights per week.
According to the results, there was a statistically significantly greater benefit in the zolpidem group than in the placebo group on patient global ratings of improvement, with no reduction in clinical efficacy over the course of the study and no evidence of rebound insomnia upon drug discontinuation. At the 12-week end point, 89.7 percent of zolpidem extended-release patients reported that the medication helped them sleep, compared with 51.4 percent of placebo patients.
"Approximately 10 percent of the population suffers from chronic insomnia. These individuals are most commonly treated with medications in clinical practice, though for many years we lacked data on the long-term medication management of insomnia," said Andrew D. Krystal, MD, of Duke University, lead author of the study. "However, recent studies document the efficacy and safety of nightly treatment with some insomnia agents for periods of up to one year. As the duration of treatment increases, the costs and risks of adverse effects associated with taking a medication nightly become increasingly important considerations. For the chronic insomnia patients who have waxing and waning symptom severity, it may be possible to decrease the costs and risks by employing non-nightly medication dosing. Consistent with this model, nearly half of insomnia patients take their medications on an 'as needed' basis. Existing studies document the risk-benefit profile of this practice with the insomnia medication zolpidem 10 mg for periods up to three months."
Insomnia is a classification of sleep disorders in which a person has trouble falling asleep, staying asleep or waking up too early. These disorders may also be defined by an overall poor quality of sleep. Insomnia is the most commonly reported sleep disorder. About 30 percent of adults have symptoms of insomnia.
On average, most adults need seven to eight hours of sleep each night to feel alert and well-rested.
The American Academy of Sleep Medicine (AASM) offers the following tips on how to get a good night's sleep:
* Follow a consistent bedtime routine.
* Establish a relaxing setting at bedtime.
* Get a full night's sleep every night.
* Avoid foods or drinks that contain caffeine, as well as any medicine that has a stimulant, prior to bedtime.
* Do not go to bed hungry, but don't eat a big meal before bedtime either.
* Avoid any rigorous exercise within six hours of your bedtime.
* Make your bedroom quiet, dark and a little bit cool.
* Get up at the same time every morning.
Those who think they might have insomnia, or another sleep disorder, are urged to consult with their primary care physician or a sleep specialist.
American Academy of Sleep Medicine
"Approximately 10 percent of the population suffers from chronic insomnia. These individuals are most commonly treated with medications in clinical practice, though for many years we lacked data on the long-term medication management of insomnia," said Andrew D. Krystal, MD, of Duke University, lead author of the study. "However, recent studies document the efficacy and safety of nightly treatment with some insomnia agents for periods of up to one year. As the duration of treatment increases, the costs and risks of adverse effects associated with taking a medication nightly become increasingly important considerations. For the chronic insomnia patients who have waxing and waning symptom severity, it may be possible to decrease the costs and risks by employing non-nightly medication dosing. Consistent with this model, nearly half of insomnia patients take their medications on an 'as needed' basis. Existing studies document the risk-benefit profile of this practice with the insomnia medication zolpidem 10 mg for periods up to three months."
Insomnia is a classification of sleep disorders in which a person has trouble falling asleep, staying asleep or waking up too early. These disorders may also be defined by an overall poor quality of sleep. Insomnia is the most commonly reported sleep disorder. About 30 percent of adults have symptoms of insomnia.
On average, most adults need seven to eight hours of sleep each night to feel alert and well-rested.
The American Academy of Sleep Medicine (AASM) offers the following tips on how to get a good night's sleep:
* Follow a consistent bedtime routine.
* Establish a relaxing setting at bedtime.
* Get a full night's sleep every night.
* Avoid foods or drinks that contain caffeine, as well as any medicine that has a stimulant, prior to bedtime.
* Do not go to bed hungry, but don't eat a big meal before bedtime either.
* Avoid any rigorous exercise within six hours of your bedtime.
* Make your bedroom quiet, dark and a little bit cool.
* Get up at the same time every morning.
Those who think they might have insomnia, or another sleep disorder, are urged to consult with their primary care physician or a sleep specialist.
American Academy of Sleep Medicine
Insomnia News and Current Insomnia Events RSSPoor sleep linked to suicidal behavior among children and adolescents with depressive episodes
A research abstract that will be presented on Thursday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS), finds a link between poor sleep and suicidal behavior among children and adolescents with depressive episodes.
REM sleep associated with overweight in children and adolescents
Short sleep time is associated with overweight in children and adolescents, a core aspect of which may be attributed to reduced REM sleep, according to a research abstract that will be presented on Thursday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).
Insomnia in parents can result in sleep problems, suicidal behavior among their offspring
A history of chronic insomnia in parents is not only associated with elevated risk for insomnia but also with elevated risks for use of hypnotics, psychopathology and suicidal behavior in adolescent offspring, according to a research abstract that will be presented on Thursday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).
Disturbed rest, activity linked to mortality in older men
It appears that disrupted rest and activity rhythms are associated with increased mortality rates among older men, according to new University of Minnesota research.
A self-help program delivered online can improve insomnia in adults
A cognitive behavioral intervention for insomnia delivered via the Internet can significantly improve insomnia in adults, according to a research abstract that will be presented on Wednesday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS).
Moderate exercise can improve the sleep quality of insomnia patients
An acute session of moderate aerobic exercise, but not heavy aerobic or moderate strength exercises, can reduce the anxiety state and improve the sleep quality of insomnia patients.
Normal sleep linked to successful aging
A research abstract that will be presented on Wednesday at SLEEP 2008, the 22nd Annual Meeting of the Associated Professional Sleep Societies (APSS), finds a link between normal sleep and healthy aging.
Insomnia among returning war vets is as severe as patients with chronic insomnia
Insomnia together with post-deployment adjustment disorders among returning war veterans is as severe as patients suffering from chronic insomnia.
Phase III pivotal results presented of VYVANSE to treat ADHD in adults
Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today presented the results of a phase III pivotal study in which VYVANSE demonstrated significant improvements in Attention Deficit Hyperactivity Disorder (ADHD) symptoms in adults and met all safety and efficacy endpoints.
Different Processes Govern Sight, Light Detection
A Johns Hopkins University biologist, in research with implications for people suffering from seasonal affective disorder and insomnia, has determined that the eye uses light to reset the biological clock through a mechanism separate from the ability to see.
More Insomnia News Articles
 | Adrenal Fatigue: The 21st Century Stress Syndrome by James L. Wilson |
 | Say Good Night to Insomnia: The Six-Week, Drug-Free Program Developed At Harvard Medical School by Gregg D. Jacobs |
 | Insomnia by Stephen King |
 | Insomniac by Gayle Greene |
 | No More Sleepless Nights by Peter Hauri, Shirley Linde |
 | 5-HTP: The Natural Way to Overcome Depression, Obesity, and Insomnia by Michael Murray |
 | The Family That Couldn't Sleep: A Medical Mystery by D.T. Max |
 | Four Seasons in Rome: On Twins, Insomnia, and the Biggest Funeral in the History of the World by Anthony Doerr |
 | The Secret Art of Seamm Jasani: 58 Movements for Eternal Youth from Ancient Tibet by Asanaro |
 | Deep Sleep (Diviniti) (Diviniti) by Glenn Harrold |
| © 2008 BrightSurf.com |